Le Lézard
Classified in: Health
Subject: SVY

Prader-Willi Syndrome Pipeline Study, H1 2020 - Analysis by Stage of Development, Drug Target, Mechanism of Action, Route of Administration and Molecule Type


DUBLIN, Jan. 24, 2020 /PRNewswire/ -- The "Prader-Willi Syndrome (PWS) - Pipeline Review, H1 2020" drug pipelines has been added to ResearchAndMarkets.com's offering.

Research and Markets Logo

This report provides an overview of the Prader-Willi Syndrome (PWS) (Genetic Disorders) pipeline landscape.

The Pharmaceutical and Healthcare latest pipeline guide Prader-Willi Syndrome (PWS) - Pipeline Review, H1 2020, provides comprehensive information on the therapeutics under development for Prader-Willi Syndrome (PWS) (Genetic Disorders), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.

The Prader-Willi Syndrome (PWS) (Genetic Disorders) pipeline guide also reviews of key players involved in therapeutic development for Prader-Willi Syndrome (PWS) and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities/Institutes, the molecules developed by Companies in Phase III, Phase II, Phase I and Preclinical stages are 5, 5, 5 and 3 respectively. Similarly, the Universities portfolio in Phase II and Preclinical stages comprises 1 and 2 molecules, respectively.

Prader-Willi Syndrome (PWS) (Genetic Disorders) pipeline guide helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.

Report Scope

Reasons to Buy

Key Topics Covered

  1. Introduction
  2. Prader-Willi Syndrome (PWS) - Overview
  3. Prader-Willi Syndrome (PWS) - Therapeutics Development
  4. Prader-Willi Syndrome (PWS) - Therapeutics Assessment
  5. Prader-Willi Syndrome (PWS) - Companies Involved in Therapeutics Development
  6. Prader-Willi Syndrome (PWS) - Drug Profiles
  7. Prader-Willi Syndrome (PWS) - Dormant Projects
  8. Prader-Willi Syndrome (PWS) - Discontinued Products
  9. Prader-Willi Syndrome (PWS) - Product Development Milestones
  10. Appendix

Companies Mentioned

For more information about this drug pipelines report visit https://www.researchandmarkets.com/r/hx600r

Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.

Media Contact:

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

SOURCE Research and Markets


These press releases may also interest you

at 03:05
To encourage balance, self-care and strength during this 2020 pandemic, Warriors Heart Clinical Director and U.S. Navy/Army Veteran Dr. Rick Boone encourages four resiliency steps. During a recent Newsmax interview, Dr. Boone emphasized, "What we're...

at 02:00
The Food Equity Initiative and Knoq, have created a "no-contact" specialty delivery service to deliver allergy-free foods to families in need during the Coronavirus outbreak. The COVID-19 pandemic is increasing food insecurity by interrupting income,...

9 avr 2020
Joe's Gluten-Free Foods is recalling Joe's Gluten-Free Foods brand Potato & Onion Perogies from the marketplace because they contain milk which is not declared on the label. People with an allergy to milk should not consume the recalled product...

9 avr 2020
Care Access Research, the leader in rapid development and management of high-performing clinical research sites, announced it launched the COVID-19 Clinical Trials Alliance to connect sites, sponsors and CROs to accelerate COVID-19 trials required...

9 avr 2020
There has been a lot of talk about ventilators and N95 masks, but CRIMADI has observed the reality is that healthcare workers are struggling with a much longer list of shortages every day. And feeling helpless in being able to save as many lives as...

9 avr 2020
The International Sleep Products Association (ISPA) today announced that US mattress manufacturing facilities across the country are working hard to produce and deliver mattresses and other critical products to fellow Americans in need. ...



News published on 24 january 2020 at 16:00 and distributed by: